By Anil Matai The Union Ministry of Health had released the draft of the New Drugs, Medical Devices and Cosmetics Bill, 2022 on July 8, 2022. This pivotal legislation, set to replace the 83-year-old Drugs and Cosmetics Act of 1940, proposed to revamp the entire regulatory framework governing the import, manufacturing, distribution, and sale of … Read more
Global pharma major Lupin Limited on Friday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Canagliflozin Tablets, 100 mg and 300 mg. According to a press statement, the approval has been granted to market a generic equivalent of Invokana … Read more
A US shortage of the new generic version of Vyvanse, an ADHD medication, is due in part to federal limits on production, according to an industry group representing generic drug makers. Manufacturers haven’t been able to secure enough raw material “to launch their products at full commercial scale,” according to a letter from the Association … Read more
The enduring effects of epilepsy reach beyond seizures, affecting interpersonal relationships, career, finances, and social status. Alongside other factors, this influence may lead to feelings of dejection, disinterest, and depression. Regrettably, epilepsy cases frequently escape detection, are underreported, and go undertreated, intensifying the difficulty of rehabilitating individuals with epilepsy. One of the leading neurologists, from … Read more
Concerns have been raised over the suitability of current FDA-approved treatments for myelofibrosis due to the negative associations with anemia. In response, the FDA has significantly increased the number of awarded orphan drug designations (ODDs) for myelofibrosis-indicated drugs in recent years. Since 2014, a total of 11 ODDs have been granted, with eight of them … Read more
Trigger warning: Eating disorders, sexual abuse, body dysmorphia Srishti (name changed), 24, loves exploring new dishes and cuisines. Although she was a picky eater as a child, she tried to savour all varieties of food as she grew up. “In 2022, I was going through a very difficult phase in my personal life which got … Read more
Metropolis Healthcare Limited on Friday announced that it has launched the Next Best Action (NBA) initiative. According to the company’s press statement, a comprehensive patient education program designed to address the alarming rise in chronic diseases. This ground-breaking initiative is fuelled by an in-depth data study involving 1,50,261 adults who underwent general body check-ups under … Read more
Ahead of World Diabetes Day, P&G Health hosted a scientific forum highlighting the importance of increasing awareness of Peripheral Neuropathy. Hosted out of Jakarta and simulcast to 6 countries, the signature event was attended by more than 1000 healthcare practitioners from across Asia-Pacific, the Middle East, India, and Africa. The forum saw deliberations on the … Read more
Bangalore-based Even Healthcare, which offers subscription-based healthcare services and insurance, is looking to turn profitable by the end of next year, encouraged by the rising demand for digital healthcare services. “The business is at a point when we’re on a $10-15 million run rate and I think we are on track to be profitable at … Read more
Novo Nordisk recently announced that its FLOW trial, which studies Ozempic (semaglutide) in diabetic patients with chronic kidney disease (CKD), will come to a halt almost one year prior to the planned completion date, as interim results alone were sufficient in proving that the treatment was successful in treating kidney failure in this patient group. … Read more